Skip to main content

Hemophilia A News (Page 2)

FDA Approves Obizur [Antihemophilic Factor (Recombinant)] for Acquired Hemophilia A

DEERFIELD, Ill., October 24, 2014 - Baxter International Inc. today announced that the United States Food and Drug Administration (FDA) has approved Obizur [Antihemophilic Factor (Recombinant),...

FDA Approves Eloctate - first Antihemophilic Factor, Fc Fusion Protein for Patients with Hemophilia A

June 6, 2014 – The U.S. Food and Drug Administration today approved Eloctate, Antihemophilic Factor (Recombinant), Fc fusion protein, for use in adults and children who have Hemophilia A. Eloctate...

NovoEight (turoctocog alfa) Receives Approval from the FDA

Bagsværd, Denmark, 16 October 2013 – Today, Novo Nordisk announced that the U.S. Food and Drug Administration (FDA) has approved its Biologics License Application (BLA) for recombinant coagulation fa...

Ask a question

To post your own question to our community, sign in or create an account.